Richard H. Booth, Director at Adamas Pharmaceuticals Inc (ADMS), sold 1,000 shares at $19.32 ($19K) on 2015-06-15, disclosed to the SEC on 2015-06-17.
Scheduled sale ($19k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADMS | SELL | 2015-03-17 | $17K | — | Filing → |
| ADMS | SELL | 2015-02-18 | $17K | — | Filing → |
| ADMS | SELL | 2015-01-20 | $17K | — | Filing → |